Large Genome Models Open New Frontiers in Bacteriophage Engineering
Researchers are applying the same AI approaches behind large language models to genomics, using large genome models to computationally design new bacteriophages—viruses that infect and kill bacteria. These engineered viruses can be made genetically distant from any naturally occurring counterparts, which could prove valuable for developing phage therapies to treat drug-resistant bacterial infections where traditional antibiotics have failed.
Bacteriophage therapy has gained attention as an alternative to antibiotics, but natural phages often face limitations: bacteria can develop resistance, and natural phage collections may not cover all pathogenic strains. By using large genome models to design entirely new viral sequences, scientists can potentially create phage variants optimized for specific therapeutic applications while sidestepping some of the resistance issues that plague both antibiotics and naturally-derived phage treatments.
The approach represents a convergence of AI's pattern-recognition capabilities with synthetic biology's goal of engineering living systems for medical benefit. As these computational tools become more sophisticated, they may accelerate the development of precision phage therapies tailored to individual patients or specific bacterial threats.
The work highlights both the promise and the sensitivity surrounding AI in biotechnology. While bacteriophages are bacteria-killing viruses rather than human pathogens, the broader capability to design novel viral genomes raises questions about biosecurity oversight and responsible development practices in the field.